Clinical trial Recruiting at 104 sites Phase 3 Interventional Ages 18 and up Women only

Orforglipron for women with stress urinary incontinence who are overweight or have obesity

Official title: A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Tablet Once Daily Compared With Placebo in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight

Run by Eli Lilly and Company · NCT07202884 · Data updated 2026-11-12

This trial will test whether orforglipron reduces urine leakage in adult women with stress urinary incontinence who are overweight or have obesity.

More Urinary Incontinence trials

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment1000 (estimated)
SponsorEli Lilly and Company
Industry-sponsored
Locations120 sites (Birmingham, Alabama and 119 other locations)
StatusRecruiting
StartedSeptember 30, 2025
Main results expectedMarch 2028
Study endsMarch 2028
Registry record updatedNovember 4, 2026
Trial IDNCT07202884 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adult women with stress urinary incontinence and a BMI of 27 kg/m2 or higher who are not pregnant, do not have diabetes, have not had recent incontinence surgery or Botox injections, and are willing to attend in-person visits at a study site are ideal candidates.

Probably not a fit

Women with type 1 or type 2 diabetes, recent urinary incontinence surgery, recent Botox injections, current medications for urinary incontinence, recent significant weight change, recent anti-obesity drug use, or who are pregnant or breastfeeding are unlikely to be eligible and may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The GZPS master protocol runs two parallel Phase 3 studies (J2A-MC-GZS1 and J2A-MC-GZS2) that randomize adult female participants with stress urinary incontinence and a BMI ≥27 to receive orforglipron or placebo. Participants will take the study medication or placebo and attend visits over about 58 weeks from screening through safety follow-up. Key exclusions include diabetes, recent urinary incontinence surgery, recent Botox or other incontinence treatments, recent large weight changes, recent anti-obesity medication use, and pregnancy or breastfeeding. The trials compare leakage outcomes and safety between orforglipron and placebo to see if the drug reduces stress-related urine loss.

Why it matters

Potential benefit: If successful, it could reduce stress-related urine leakage and improve daily comfort and quality of life for overweight women with SUI.

How similar studies have gone: Previous weight-loss interventions, including some GLP-1–based approaches, have reduced urinary incontinence in other trials, but using orforglipron specifically for SUI is a novel application.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Have a body mass index (BMI) of 27 kilograms per square meter (kg/m2) or higher at screening
* Have a diagnosis of stress urinary incontinence

Exclusion Criteria:

* Have had urinary incontinence surgery
* Have recently received onabotulinumtoxin A (Botox) bladder injections or currently taking medications for urinary incontinence
* Have given birth within one year of screening
* Have had a change in body weight of more than 11 pounds within 90 days prior to screening
* Have used any anti-obesity medication or alternative weight loss remedies within 180 days prior to screening
* Have type 1 diabetes, type 2 diabetes, or any other type of diabetes
* Have had a cardiovascular health condition within 90 days prior to screening
* Are pregnant, intending to be pregnant, breastfeeding, or intending to breastfeed for the duration of the study

Where it's running

  • University of Alabama -The Kirklin Clinic
    Birmingham, Alabama, United States
    Recruiting
  • AMR Clinical
    Mobile, Alabama, United States
    Recruiting
  • Matrix Clinical Research
    Los Angeles, California, United States
    Recruiting
  • Alarcon Urology Center
    Montebello, California, United States
    Recruiting
  • Colorado Clinical Research
    Lakewood, Colorado, United States
    Recruiting
  • AMR Clinical
    Fort Myers, Florida, United States
    Recruiting
Show 44 more locations
  • Altus Research
    Lake Worth, Florida, United States
    Recruiting
  • New Age Medical Research Corporation
    Miami, Florida, United States
    Recruiting
  • Emerald Coast OBGYN Clinical Research
    Panama City, Florida, United States
    Recruiting
  • Teak Research Consults
    Lawrenceville, Georgia, United States
    Recruiting
  • Arcturus Healthcare , PLC, Troy Internal Medicine Research Division
    Troy, Michigan, United States
    Recruiting
  • OB/GYN Associates of Erie
    Erie, Pennsylvania, United States
    Recruiting
  • Next Level Urgent Care
    Houston, Texas, United States
    Recruiting
  • Innovative Medical Research of Texas
    Houston, Texas, United States
    Recruiting
  • Health Research of Hampton Roads, Inc.
    Newport News, Virginia, United States
    Recruiting
  • Urology of Virginia
    Virginia Beach, Virginia, United States
    Recruiting
  • Northwest Clinical Research Center
    Bellevue, Washington, United States
    Recruiting
  • Seattle Clinical Research Center
    Seattle, Washington, United States
    Recruiting
  • OCT Research ULC
    Kelowna, Canada
    Recruiting
  • Kelowna Health and Memory Centre
    Kelowna, Canada
    Recruiting
  • Alpha Recherche Clinique - Lévis
    Lévis, Canada
    Recruiting
  • The Fe/Male Health Centre
    Oakville, Canada
    Recruiting
  • Alpha Recherche Clinique
    Québec, Canada
    Recruiting
  • ALPHA Recherche Clinique
    Québec, Canada
    Recruiting
  • CaRe Clinic
    Red Deer, Canada
    Recruiting
  • Sunnybrook Research Institute
    Toronto, Canada
    Recruiting
  • Peking University People's Hospital
    Beijing, China
    Recruiting
  • Xuanwu Hospital Capital Medical University
    Beijing, China
    Recruiting
  • Peking University Third Hospital
    Beijing, China
    Recruiting
  • Peking University First Hospital
    Beijing, China
    Recruiting
  • Sichuan Provincial People's Hospital
    Chengdu, China
    Recruiting
  • Chengdu Women and Children Center Hospital
    Chengdu, China
    Recruiting
  • 2nd Affiliated Hospital Chongqing Medical University
    Chongqing, China
    Recruiting
  • Zhujiang Hospital
    Guangzhou, China
    Recruiting
  • The First Affiliated Hospital of Jinan University
    Guangzhou, China
    Recruiting
  • Zhejiang Provincial People's Hospital
    Hangzhou, China
    Recruiting
  • Second Affiliated hospital of Anhui Medical University
    Hefei, China
    Recruiting
  • Gansu Provincial Hospital
    Lanzhou, China
    Recruiting
  • Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School
    Nanjing, China
    Recruiting
  • Ningbo First Hospital
    Ningbo, China
    Recruiting
  • Obstetrics & Gynecology Hospital of Fudan University
    Shanghai, China
    Recruiting
  • Peking University Shenzhen Hospital
    Shenzhen, China
    Recruiting
  • The Second Affiliated Hospital of Soochow University
    Suzhou, China
    Recruiting
  • Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology
    Wuhan, China
    Recruiting
  • The First Affiliated Hospital of Xi'an Jiaotong University
    Xi'an, China
    Recruiting
  • The First Affiliated hospital of Xiamen University
    Xiamen, China
    Recruiting
  • Hasegawa Hospital - Arakawa
    Arakawa City, Japan
    Recruiting
  • Takasu Nephrology and Urology Clinic
    Chiba, Japan
    Recruiting
  • Yotsuya Medical Cube
    Chiyoda City, Japan
    Recruiting
  • St. Luke's International Hospital
    Chūōku, Japan
    Recruiting

+70 more sites. See ClinicalTrials.gov for the full list.

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.